C4 Therapeutics's total assets for Q4 2024 were $319.52M, a decrease of -8.60% from the previous quarter. CCCC total liabilities were $124.38M for the fiscal quarter, a -6.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.